News for hackers. Stuff that matters.

A comment on Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval. Parent comment

Re:Third member of U.S. FDA advisory panel resigns over Alzh... by CogitoCogito on Friday June 11, 2021 @10:55AM (#27474238)
> Which is reasonable to me. It takes years to test drugs like this and if a patient and her doctor believe this is the best treatment, the FDA shouldn't prevent them from getting access to it.

I can understand this argument as long as Biogen isn't making any money off of these drugs. In fact, they should really be losing money if anything since they are gaining value from the data.

[ Parent | on HN ]
Re:Third member of U.S. FDA advisory panel resigns over Alzh... by f6v on Friday June 11, 2021 @11:16AM (#27474507)
Big Pharma bad, but making drugs is incredibly costly. Especially in Alzheimers, where so many candidates failed. It's incredible someone is even trying after so many failures.
[ Parent | on HN ]
Re:Third member of U.S. FDA advisory panel resigns over Alzh... by CogitoCogito on Friday June 11, 2021 @11:24AM (#27474596)
That's true, but I don't really see why the drug companies shouldn't pay those costs.
[ Parent | on HN ]
Re:Third member of U.S. FDA advisory panel resigns over Alzh... by alexslobodnik on Friday June 11, 2021 @11:38AM (#27474783)
The second order effects may be that they wouldn't want to even try to develop a drug.

What world do you want to live in? (Rhetorical)

[ Parent | on HN ]
Re:Third member of U.S. FDA advisory panel resigns over Alzh... by mcguire on Friday June 11, 2021 @02:25PM (#27476843)
The third order effects may be continued erosion of respect for the federal government's regulatory process. Tread carefully. (And make lots of money while you can.)
[ Parent | on HN ]
Re:Third member of U.S. FDA advisory panel resigns over Alzh... by jhayward on Friday June 11, 2021 @02:50PM (#27477106)
And blowing out the drug budget for medicare for a very expensive but futile treatment.
[ Parent | on HN ]
Re:Third member of U.S. FDA advisory panel resigns over Alzh... by tinus_hn on Saturday June 12, 2021 @02:37AM (#27482150)
If you say they should pay the costs, they should also reap the rewards, so in that case you have to accept that drugs are really expensive.
[ Parent | on HN ]
Re:Third member of U.S. FDA advisory panel resigns over Alzh... by thesausageking on Friday June 11, 2021 @11:05AM (#27474359)
The big question is will insurance companies and CMS pay for it, and that's not up to the FDA. That debate is occurring right now and will likely create new precedents.
[ Parent | on HN ]